PK-188

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NamePK-188
Drug Alias NameJAK1/JAK2 Inhibitors (Pulmokine/YM BioSciences)PK-188
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTyrosine-protein kinase JAK2 inhibitorsTyrosine-protein kinase JAK1 inhibitors
TargetsTyrosine-protein kinase JAK2Tyrosine-protein kinase JAK1
Therapy Area/IndicationsHypertension, Pulmonary
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesYM BioSciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPulmokine IncYM BioSciences IncGilead Sciences Inc
Active IndicationsN/A
Inactive IndicationsHypertension, Pulmonary

Other Information

ATC CodeN/A
Related LinksN/A